Diabetes management in the new millennium using insulin pump therapy

Diabetes/Metabolism Research and Reviews

Volumn 18, Issue SUPPL. 1, 2002, Pages

  Bode, Bruce W ^a   Sabbah, Hassan T ^a   Gross, Todd M ^b   Fredrickson, Linda P ^b   Davidson, Paul C ^a  

^a ATLANTA DIABETES ASSOCIATES   (United States)

^b MEDTRONIC INC   (United States)

Author keywords

Continuous subcutaneous insulin infusion; Insulin pump therapy; Intensive diabetes management

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; KETONE;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL ORGAN; BLOOD GLUCOSE MONITORING; BOLUS INJECTION; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC KETOACIDOSIS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; EXERCISE; FEEDBACK SYSTEM; FEEDING BEHAVIOR; FEMALE; FOLLOW UP; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK MANAGEMENT; SCHOOL CHILD; WEIGHT GAIN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSION PUMPS, IMPLANTABLE; INSULIN; MALE; MIDDLE AGED;

EID: 0036110458     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.205     Document Type: Article

References (32)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Pharmacokinetics of continuous subcutaneous insulin infusion
3. Insulin pharmacokinetics
4. Lessons from studies of insulin pharmacokinetics
5. Continuous subcutaneous insulin infusion: An approach to achieving normoglycemia
6. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump
7. Treatment of insulin-dependent diabetes with portable insulin infusion devices
8. Intensive conventional and insulin pump therapies in adult type 1 diabetes: A crossover study
9. Implementation of treatment protocols in the Diabetes Control and Complications Trial
10. Long-term safety, efficacy and side-effects of continuous subcutaneous insulin infusion treatment for type I (insulin-dependent) diabetes mellitus: A one centre experience
11. Long-term pump use and SMBG in 205 patients
12. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes
13. Continuous subcutaneous insulin infusion for the treatment of diabetic patients with hypoglycemia unawareness
14. An assessment of continuous subcutaneous insulin infusion therapy in an academic diabetes clinic
15. A 'new' way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes
16. Determinants of glycemic control in insulin pump therapy
17. Continuous subcutaneous insulin infusion (CSII): A study comparing lispro to regular human insulin
18. Insulin lispro in CSII: Results of a double-blind cross-over study
19. Use of insulin lispro in continuous subcutaneous insulin infusion treatment
20. 1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps
21. Continuous subcutaneous insulin infusion for treatment of type 2 diabetes mellitus
22. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: Results from the DCCT
23. The frequency of diabetic ketoacidosis and hypoglycemia coma during treatment with continuous subcutaneous insulin infusion
24. Acute complications associated with insulin infusion pump therapy. Report of experience with 161 patients
25. Breaking the age barrier: A comparison of continuous subcutaneous insulin infusion in adolescents and adults
26. Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus
27. Insulin pump treatment for recurrent ketoacidosis in adolescence
28. How diabetes specialists treat their own diabetes: Findings from a study of the AADE and ADA membership
29. A recent assessment of continuation rates for continuous subcutaneous insulin infusion (CSII)
30. Position Statement - Continuous Subcutaneous Insulin Infusion
31. Factors affecting the reduction of starting insulin dose in CSII
32. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: A pilot study